The global hematology testing is perceived to be a market with high attractiveness, by the investors. Strong investments in this field aided by considerable research activities by both public and private sectors are expected to propel the growth of the market in the years that follow. In spite of having several favorable factors, investments into the market are being hindered by the slow adoption rate of expensive hematology testing devices in low income and middle-come countries of the world. The most promising way to venture into this market and gain measurable profits is through innovations and development of advanced, compact, accurate, and user-friendly hematology analyzers. Sysmex Corporation, headquartered in Japan is catering to in-vitro diagnostics, offers wide range of hematology testing products ranging from hematology analyzers and flow cytometers to reagents, stains, controls, and calibrators. The huge product contribution of the company resulted in its market domina...